These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33799180)

  • 1. Novel coumarin-isatin hybrids as potent antileishmanial agents: Synthesis, in silico and in vitro evaluations.
    Khatoon S; Aroosh A; Islam A; Kalsoom S; Ahmad F; Hameed S; Abbasi SW; Yasinzai M; Naseer MM
    Bioorg Chem; 2021 May; 110():104816. PubMed ID: 33799180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antileishmanial activity of novel pyridinium-hydrazone derivatives.
    Alptuzun V; Cakiroglu G; Limoncu ME; Erac B; Hosgor-Limoncu M; Erciyas E
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):960-7. PubMed ID: 22803671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzimidazole derivatives endowed with potent antileishmanial activity.
    Tonelli M; Gabriele E; Piazza F; Basilico N; Parapini S; Tasso B; Loddo R; Sparatore F; Sparatore A
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):210-226. PubMed ID: 29233048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Sitosterol from Ifloga spicata (Forssk.) Sch. Bip. as potential anti-leishmanial agent against leishmania tropica: Docking and molecular insights.
    Majid Shah S; Ullah F; Ayaz M; Sadiq A; Hussain S; Ali Shah AU; Adnan Ali Shah S; Wadood A; Nadhman A
    Steroids; 2019 Aug; 148():56-62. PubMed ID: 31085212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Hydrophilic Riminophenazines as Potent Antiprotozoal Agents.
    Bassanini I; Parapini S; Basilico N; Sparatore A
    ChemMedChem; 2019 Nov; 14(22):1940-1949. PubMed ID: 31658408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
    Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine-1,1-dioxide derivatives.
    Mangwegape DK; Zuma NH; Aucamp J; N'Da DD
    Arch Pharm (Weinheim); 2021 May; 354(5):e2000280. PubMed ID: 33491807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological activity, and mechanism of action of new 2-pyrimidinyl hydrazone and N-acylhydrazone derivatives, a potent and new classes of antileishmanial agents.
    Coimbra ES; Nora de Souza MV; Terror MS; Pinheiro AC; da Trindade Granato J
    Eur J Med Chem; 2019 Dec; 184():111742. PubMed ID: 31605866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
    Saad SM; Ghouri N; Perveen S; Khan KM; Choudhary MI
    Eur J Med Chem; 2016 Jan; 108():13-20. PubMed ID: 26619389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
    Abamor ES; Allahverdiyev AM; Bagirova M; Rafailovich M
    Acta Trop; 2017 May; 169():30-42. PubMed ID: 28111133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.
    Istanbullu H; Bayraktar G; Akbaba H; Cavus I; Coban G; Debelec Butuner B; Kilimcioglu AA; Ozbilgin A; Alptuzun V; Erciyas E
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e1900325. PubMed ID: 32484266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes.
    Napolitano HB; Silva M; Ellena J; Rodrigues BD; Almeida AL; Vieira PC; Oliva G; Thiemann OH
    Braz J Med Biol Res; 2004 Dec; 37(12):1847-52. PubMed ID: 15558191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents.
    Rashid U; Sultana R; Shaheen N; Hassan SF; Yaqoob F; Ahmad MJ; Iftikhar F; Sultana N; Asghar S; Yasinzai M; Ansari FL; Qureshi NA
    Eur J Med Chem; 2016 Jun; 115():230-44. PubMed ID: 27017551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
    Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN
    Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone.
    Mahmoudvand H; Tavakoli R; Sharififar F; Minaie K; Ezatpour B; Jahanbakhsh S; Sharifi I
    Pharm Biol; 2015 Jul; 53(7):1052-7. PubMed ID: 25471014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis.
    Rosypal AC; Werbovetz KA; Salem M; Stephens CE; Kumar A; Boykin DW; Hall JE; Tidwell RR
    J Parasitol; 2008 Jun; 94(3):743-9. PubMed ID: 18605790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
    Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
    Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
    Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
    Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Novel Quaternary Ammonium Salts and Their in Vitro Antileishmanial Activity and U-937 Cell Cytotoxicity.
    Duque-Benítez SM; Ríos-Vásquez LA; Ocampo-Cardona R; Cedeño DL; Jones MA; Vélez ID; Robledo SM
    Molecules; 2016 Mar; 21(4):381. PubMed ID: 27043509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.